塔莫西芬视网膜病变:一个全面的审查
Stephen Tenney1, Aruoriwo Oboh-Weilke2, David Wagner2
1Georgetown University School of Medicine, Washington, DC, USA.
Survey of ophthalmology
|July 23, 2023
概括
乳腺癌药物塔莫西芬可在多达12%的患者中引起视网膜病变. 建议每6个月进行一次早期光学连贯性断层扫描查,对于长期接受他莫西芬治疗的患者.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 塔莫西芬是乳腺癌治疗的关键选择性雌激素受体调节剂 (SERM).
- 视网膜毒性是他莫西芬治疗的已知副作用.
- 长期使用,特别是超过2年的每天20毫克,会增加视网膜病变的风险.
研究的目的:
- 审查塔莫西芬诱导视网膜病变的发生率和特征.
- 讨论当前的管理策略及其局限性.
- 推用于早期检测的查协议.
主要方法:
- 审查病例报告和有关他莫西芬视网膜病变的现有研究.
- 对报告的视网膜变化和视力敏度结果的分析.
- 评估潜在的治疗干预措施和查方法.
主要成果:
- 视网膜病变影响了多达12%的患者,这些患者每天服用他莫西芬20毫克>2年.
- 有症状的视力敏度变化发生在一半受影响的患者中.
- 视网膜的变化包括晶体沉积物,黄斑胀,超反射沉积物和远距离切割.
结论:
- 停止服用他莫西芬可能无法逆转一旦建立的视力敏度损失.
- 内疗法需要进一步的研究.
- 建议每6个月进行光学连贯性断层扫描 (OCT) 查,对服用他莫西芬≥2年的患者进行视网膜变化监测.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Pharmacovigilance
895
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
895
Glaucoma: Overview
623
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
623
The Retina
69.2K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
69.2K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


